In the GBS patients, they found a reduction in the percentage of CD4+ CD25+, CD3+, and CD8+ T cells and total cell population expression of CD95 (Fas), while an increase in Bcl-2 expression within the CD4+ CD25+ T cell population was noted. This evidence concerns the gene CD8A and Guillain-Barre syndrome.